French CRO Excelya inks deal with Veeva for data platform
2022-11-09
临床研究
Preview
来源: FierceBiotech
U.S.-based Veeva Systems has signed European CRO Excelya to use its suite of clinical trial management tools for data cleaning and reporting in clinical trials.
Excelya has brought on Veeva Systems’ suite of clinical trial management tools for data cleaning and reporting in clinical trials.
The full-service French CRO inked the deal with the cloud software provider to speed database build cycles and reduce the downtime that can happened during midstudy design amendments, according to a Nov. 9 press release.
Financial terms of the contract weren’t disclosed.
"Effective data capture is key to running successful clinical trials," Paul MacDonald, Veeva’s senior director of strategy, said in the press release. “Excelya's addition of Veeva Vault EDC is an important step in transforming its approach to data management by simplifying study builds and trial execution for faster development of new medicines."
Veeva, which is based near San Francisco, has seen a string of companies recently opt for its services. In October, the company signed up 40 CROs and more than 120 clinical trial sites to use its suite of clinical trial management tools. Among the CROs signed were Labcorp, ParexelParexel and Thermo Fisher’s PPD clinical trial division.
The company’s Vault platform was designed with metrics that allow CROs to improve the management of their study performances and increase transparency for sponsors. Vault also makes it easier for sponsors to collaborate and share information in real time.
Excelya, which has been growing its European operations, announced in July that three CROs had joined its group: Zeincro, The Clinical Company and Koehler eClinical.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。